ask="27.95"
ask_size="300"
average_daily_volume="50016"
bid="N/A"
bid_size="N/A"
book_value="-19.19"
change="+0.45"
change_from_200_day_moving_average="0.18"
change_from_50_day_moving_average="0.09"
change_from_52_week_high="-12.62"
change_From_52_week_low="1.31"
change_in_percent="+6.47%"
close="7.40"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.04"
ebitda="-18.31M"
eps_estimate_current_year="-1.07"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.41"
ex_dividend_date="N/A"
float_shares="832000"
high="7.56"
high_52_weeks="20.02"
last_trade_date="2/27/2017"
last_trade_price="7.40"
last_trade_size="100"
last_trade_time="3:59pm"
low="6.56"
low_52_weeks="6.09"
market_capitalization="18.03M"
moving_average_200_day="7.22"
moving_average_50_day="7.31"
name="KalVista Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.64"
open="6.93"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+2.51%"
percent_change_from_50_day_moving_average="+1.19%"
percent_change_from_52_week_high="-63.04%"
percent_change_from_52_week_low="+21.51%"
previous_close="6.95"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="9.56"
revenue="1.77M"
shares_outstanding="2437000"
short_ratio="1.19"
stock_exchange="NGM"
symbol="KALV"
volume="60482"
weeks_range_52="6.09 - 20.02"
